Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-03-06 @ 1:17 PM
Study NCT ID:
NCT03666559
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-29
First Post:
2018-06-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-23
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-15
First Submit QC Date:
None
Study First Post Date:
2018-09-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-28
Last Update Post Date:
2024-02-29
Last Update Post Date Type:
ACTUAL